Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Samsara BioCapital
3285
Samsara BioCapital
Suggest edits
Also headquartered in Palo Alto
Tesla
VMware
Theranos
DoorDash
Waze
Palantir
Hewlett-Packard
NEST
Pebble
Accel
Companies in the same industry
Goodwater Capital
Lerer Hippeau Ventures
Red Swan
CDC Group
Greycroft Partners
LetsVenture
Obvious Ventures
Tribeca Venture Partners
Kr Space
Canopy
Overview
News
Investments
17
Portfolio
Portfolio Tracker
Add info
Pulse 2.0
Allakos (ALLK) Stock: Why It Surged 21.73% Today
Pulse 2.0
Chinook Therapeutics (KDNY) Stock: Why It Increased 4.57% Today
Pulse 2.0
Sutro Biopharma (STRO) Stock: Why It Surged Over 19% Today
Pulse 2.0
Atreca (BCEL) Stock: Why The Price Is Much Higher Today
Pulse 2.0
Sutro Biopharma Stock (STRO): Why The Price Substantially Fell
Pulse 2.0
Sutro Biopharma Stock (STRO): Why The Price Substantially Fell Today
Pulse 2.0
Sutro Biopharma Stock (STRO): Why The Price Increased Today
Pulse 2.0
Allakos Stock (ALLK): Why The Price Substantially Dropped Today
GeekWire
Chinook Therapeutics helps form China-based biotech venture to treat kidney disease
$78,000,000
Venture capital (Series B)
MedCity News
Exo Therapeutics adds $78M as cancer, inflammation drugs march toward clinic
neurons.AI
Utah AI/biotech innovator Recursion Pharmaceuticals on a roll, doubling downtown HQ
neurons.AI
Best in Tech Awards 2021: Delfi Diagnostics
TechCrunch
ElevateBio raises $525M to advance its cell and gene therapy technologies
$85,000,000
Venture capital (Series A)
GeekWire
Notch Therapeutics raises $85M for cancer treatments and plans to open Seattle location
$100,000,000
Venture capital (Series A)
neurons.AI
Delfi Diagnostics Nets $100M in Series A Financing, Plans Multi-Cancer Screening Test
neurons.AI
Delfi Diagnostics Announces $100 Million Series A Financing to Develop a New Class of Early …
$71,500,000
Venture capital (Series B)
FinSMEs
A2 Biotherapeutics Closes $71.5M Series B Funding
$100,000,000
Undisclosed
FinSMEs
Flame Biosciences Completes $100M Common Stock Financing
$239,000,000
Venture capital (Series D)
FinSMEs
Recursion Raises $239M in Series D Equity Financing
Forbes Tech
Recursion Pharmaceuticals Raises $239 Million And Partners With Bayer For AI Drug Discovery